CHDI Foundation is a nonprofit organization founded in 2003 with the goal of rapidly discovering and developing drugs to delay or slow Huntington's disease (HD). Based in New York, New York, the organization collaborates with academic and industrial scientists worldwide to increase understanding of HD and hasten the development of therapies. CHDI Foundation employs 97 individuals and is supported by CHDI Management, which provides administrative, management, and contracting services.
CHDI Foundation's mission is to accelerate the development of treatments for HD by funding research and facilitating collaboration among scientists. The organization focuses on innovative research and operational efficiency to achieve its goals. CHDI Foundation's work is crucial for advancing the understanding and treatment of Huntington's disease.
CHDI Management, with offices in Los Angeles, New York, and Princeton, supports CHDI Foundation and other non-profit organizations dedicated to HD research. This support ensures that CHDI Foundation can maintain its focus on research and development while relying on CHDI Management for administrative and operational services.
| Ownership Private Company |
B2B professionals should contact CHDI Foundation for opportunities in drug development research and collaboration. The organization's focus on innovative research and global collaboration makes it a valuable partner for companies in the pharmaceutical and biotechnology sectors.
Sales teams selling pharmaceutical research services, recruiters seeking roles in biotechnology, and partners offering research collaboration opportunities should reach out to CHDI Foundation.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with CHDI Foundation